-
1
-
-
0036946710
-
Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion
-
J.B. Jonas, I. Kreissig, and R.F. Degenring Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 240 9 2002 782 783
-
(2002)
Graefes Arch Clin Exp Ophthalmol
, vol.240
, Issue.9
, pp. 782-783
-
-
Jonas, J.B.1
Kreissig, I.2
Degenring, R.F.3
-
2
-
-
79955552475
-
Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion
-
X. Ding, J. Li, X. Hu, S. Yu, J. Pan, and S. Tang Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion Retina 31 5 2011 838 845
-
(2011)
Retina
, vol.31
, Issue.5
, pp. 838-845
-
-
Ding, X.1
Li, J.2
Hu, X.3
Yu, S.4
Pan, J.5
Tang, S.6
-
3
-
-
79551548893
-
Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10
-
I.U. Scott, P.C. VanVeldhuisen, and N.L. Oden Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10 Ophthalmology 118 2 2011 345 352
-
(2011)
Ophthalmology
, vol.118
, Issue.2
, pp. 345-352
-
-
Scott, I.U.1
Vanveldhuisen, P.C.2
Oden, N.L.3
-
4
-
-
61349153538
-
SCORE Study report 1: Baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion
-
I.U. Scott, P.C. VanVeldhuisen, and N.L. Oden SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion Ophthalmology 116 3 2009 504 512
-
(2009)
Ophthalmology
, vol.116
, Issue.3
, pp. 504-512
-
-
Scott, I.U.1
Vanveldhuisen, P.C.2
Oden, N.L.3
-
5
-
-
84862817252
-
Ranibizumab for macular edema due to retinal vein occlusions: Long-term follow-up in the HORIZON trial
-
J.S. Heier, P.A. Campochiaro, and L. Yau Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial Ophthalmology 119 4 2012 802 809
-
(2012)
Ophthalmology
, vol.119
, Issue.4
, pp. 802-809
-
-
Heier, J.S.1
Campochiaro, P.A.2
Yau, L.3
-
6
-
-
84862779327
-
Vascular endothelial growth factor trap-eye for macular edema secondary to central retinal vein occlusion: Six-month results of the Phase 3 COPERNICUS Study
-
D. Boyer, J. Heier, and D.M. Brown Vascular endothelial growth factor trap-eye for macular edema secondary to central retinal vein occlusion: six-month results of the Phase 3 COPERNICUS Study Ophthalmology 119 5 2012 1024 1032
-
(2012)
Ophthalmology
, vol.119
, Issue.5
, pp. 1024-1032
-
-
Boyer, D.1
Heier, J.2
Brown, D.M.3
-
7
-
-
77952889477
-
Ranibizumab for macular edema following central retinal vein occlusion: Six-month primary end point results of a phase III study
-
D.M. Brown, P.A. Campochiaro, and R.P. Singh Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 6 2010 1124 1133.e1121
-
(2010)
Ophthalmology
, vol.117
, Issue.6
-
-
Brown, D.M.1
Campochiaro, P.A.2
Singh, R.P.3
-
8
-
-
0037231664
-
Cytokine traps: Multi-component, high-Affinity blockers of cytokine action
-
A.N. Economides, L.R. Carpenter, and J.S. Rudge Cytokine traps: multi-component, high-Affinity blockers of cytokine action Nat Med 9 1 2003 47 52
-
(2003)
Nat Med
, vol.9
, Issue.1
, pp. 47-52
-
-
Economides, A.N.1
Carpenter, L.R.2
Rudge, J.S.3
-
9
-
-
0037143764
-
VEGF-Trap: A VEGF blocker with potent antitumor effects
-
J. Holash, S. Davis, and N. Papadopoulos VEGF-Trap: a VEGF blocker with potent antitumor effects Proc Natl Acad Sci U S A 99 17 2002 11393 11398
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, Issue.17
, pp. 11393-11398
-
-
Holash, J.1
Davis, S.2
Papadopoulos, N.3
-
10
-
-
84865129521
-
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
-
N. Papadopoulos, J. Martin, and Q. Ruan Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab Angiogenesis 15 2 2012 171 185
-
(2012)
Angiogenesis
, vol.15
, Issue.2
, pp. 171-185
-
-
Papadopoulos, N.1
Martin, J.2
Ruan, Q.3
-
11
-
-
43649083100
-
Predicted biological activity of intravitreal VEGF Trap
-
M.W. Stewart, and P.J. Rosenfeld Predicted biological activity of intravitreal VEGF Trap Br J Ophthalmol 92 5 2008 667 668
-
(2008)
Br J Ophthalmol
, vol.92
, Issue.5
, pp. 667-668
-
-
Stewart, M.W.1
Rosenfeld, P.J.2
-
12
-
-
0022347471
-
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group
-
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group Arch Ophthalmol 103 12 1985 1796 1806
-
(1985)
Arch Ophthalmol
, vol.103
, Issue.12
, pp. 1796-1806
-
-
-
13
-
-
0028802677
-
Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report
-
Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report Ophthalmology 102 10 1995 1425 1433
-
(1995)
Ophthalmology
, vol.102
, Issue.10
, pp. 1425-1433
-
-
-
14
-
-
41149085598
-
Ranibizumab for macular edema due to retinal vein occlusions: Implication of VEGF as a critical stimulator
-
P.A. Campochiaro, G. Hafiz, and S.M. Shah Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 4 2008 791 799
-
(2008)
Mol Ther
, vol.16
, Issue.4
, pp. 791-799
-
-
Campochiaro, P.A.1
Hafiz, G.2
Shah, S.M.3
-
15
-
-
84864444516
-
One-year outcomes of the da VINCI study of VEGF trap-eye in eyes with diabetic macular edema
-
D.V. Do, Q.D. Nguyen, and D. Boyer One-year outcomes of the DA VINCI study of VEGF trap-eye in eyes with diabetic macular edema Ophthalmology 119 8 2012 1658 1665
-
(2012)
Ophthalmology
, vol.119
, Issue.8
, pp. 1658-1665
-
-
Do, D.V.1
Nguyen, Q.D.2
Boyer, D.3
-
16
-
-
79958843614
-
Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: Twelve-month outcomes of a phase III study
-
P.A. Campochiaro, D.M. Brown, and C.C. Awh Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study Ophthalmology 118 10 2011 2041 2049
-
(2011)
Ophthalmology
, vol.118
, Issue.10
, pp. 2041-2049
-
-
Campochiaro, P.A.1
Brown, D.M.2
Awh, C.C.3
-
17
-
-
84863320414
-
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-year results
-
D.F. Martin, M.G. Maguire, and S.L. Fine Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 7 2012 1388 1398
-
(2012)
Ophthalmology
, vol.119
, Issue.7
, pp. 1388-1398
-
-
Martin, D.F.1
Maguire, M.G.2
Fine, S.L.3
|